Latest news
FDA Approves Orzeyful, First Drug Targeting Underlying Cause of Narcolepsy - Drug TopicsDrug Topics · Thu, 06 Aug 2026 13:44:14 GMTRenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:43:56 GMTFDA Approves First Orexin-Targeting Drug for Narcolepsy Type 1 - Sleep ReviewSleep Review · Wed, 05 Aug 2026 22:18:00 GMTKorea’s IMGT launches world-first confirmatory trial for ultrasound drug delivery - CHOSUNBIZ - ChosunbizChosunbiz · Tue, 28 Jul 2026 07:00:00 GMT